Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F24243)
Formulation Name
Etoposide Phosphate eq 100mg base/vial injectable
Company
E.R. Squibb & Sons L.L.C.; H2-Pharma
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Etoposide
DMNH3PG
Acute myelogenous leukaemia
2A41
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Dextran
E00466
4125253
Lyophilization aid
Sodium citrate anhydrous
E00102
6224
Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
--------------------